Alphapharm can’t get docs ahead of hearing on injector pen injunction
Healthcare 2018-09-18 9:41 pmBy Cat Fredenburgh
Please login to bookmark Close

Generic drug company Alphapharm has lost a bid for documents it claimed would show Sanofi-Aventis suspected as early as 2015 that patents for one of its injector pens may be invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au